On Friday, shares of Dice Therapeutics (NASDAQ: DICE) experienced volatile short activity. After the activity, the stock price went up +0.19% to $46.7. The overall sentiment for DICE has been Bullish.
Guggenheim cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a neutral rating in a report published on Wednesday morning, The Fly reports. DICE has been the topic of several other reports. Cowen assumed coverage on shares of DICE Therapeutics in a research note on Wednesday, March 1st. They set […]
SVB Securities cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from an outperform rating to a market perform rating in a report issued on Wednesday, The Fly reports. A number of other brokerages have also recently weighed in on DICE. Wells Fargo & Company upped their price objective on shares of DICE Therapeutics from […]
SVB Securities downgraded shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from an outperform rating to a market perform rating in a report released on Wednesday, The Fly reports. DICE has been the topic of several other research reports. TD Cowen started coverage on shares of DICE Therapeutics in a research note on Wednesday, March […]
Guggenheim cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a neutral rating in a research report report published on Wednesday, The Fly reports. Other equities research analysts also recently issued reports about the stock. TD Cowen assumed coverage on shares of DICE Therapeutics in a research note on Wednesday, […]